BioPorto Enters Global Distribution Partnership with Beckman Coulter for Acute Kidney Injury NGAL Tests [Yahoo! Finance]
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Yahoo! Finance
COPENHAGEN, DENMARK and BOSTON, MA, USA, October 28, 2024 (GLOBE NEWSWIRE) – BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI), today announced that it has entered into a global distribution partnership with Beckman Coulter, Inc. , a global clinical diagnostics leader. Beckman Coulter will distribute BioPorto's neutrophil gelatinase-associated lipocalin (NGAL) tests for use on Beckman Coulter family of DxC and AU clinical chemistry analyzers. Per the agreement, Beckman Coulter will initially distribute BioPorto's NGAL test in Europe followed by distribution in the United States pending US Food and Drug Administration (FDA) marketing clearance for ProNephro AKI (NGAL) for use on the Beckman Coulter's analyzers. The agreement allows for expansion into other geographic areas. Kathleen Orland, Senior Vice President and General Manager, Clinical Chemistry and Immunoassay, of B
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Danaher Co. (NYSE: DHR) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $285.00 price target on the stock.MarketBeat
- Videojet to Showcase Innovative Coding and Marking Solutions at Pack Expo 2024 [Yahoo! Finance]Yahoo! Finance
- ViewSonic Launches its First Thunderbolt 4 Docking Monitor [Yahoo! Finance]Yahoo! Finance
- X-Rite, Pantone, and Sun Chemical Add Color Libraries to PantoneLIVE for Extruded Aluminum Aerosol PackagingPR Web
- DNA Synthesis Market to Grow by USD 6.5 Billion from 2024-2028, Driven by Rising Demand for DNA-Based Therapeutics, AI-Powered Report by Technavio [Yahoo! Finance]Yahoo! Finance
DHR
Earnings
- 10/22/24 - Beat
DHR
Sec Filings
- 10/28/24 - Form 4
- 10/28/24 - Form 4
- 10/28/24 - Form 4
- DHR's page on the SEC website